Skip to main content
eBioMedicine logoLink to eBioMedicine
. 2019 Oct 24;49:389–390. doi: 10.1016/j.ebiom.2019.10.026

Corrigendum to ‘MiR-873/PD-L1 axis regulates the stemness of breast cancer cells’ EBioMedicine 41 (2019) 395–407

Lanlan Gao a,b,1, Qianqian Guo a,b,1, Xiaoman Li c, Xuan Yang a,b, Haiwei Ni a,b, Ting Wang a,b, Qiong Zhao a,b, Hai Liu a,b, Yingying Xing a,b, Tao Xi a,b,, Lufeng Zheng a,b,
PMCID: PMC6945241  PMID: 31668879

The published version of this article contained errors in Fig. 3e [1]. The corrected Fig. 3 is given below, the authors declare that the corrections do not change the results or conclusions of this paper and apologize for any inconvenience this may have caused.

Fig. 3.

Fig 3

miR-873 attenuated the stemness of breast cancer cells through PD-L1. (a, b) The expression of stemness signatures (OCT3/4, ALDH1A1) was detected in MCF-7 cells with miR-873 knockdown or PD-L1 overexpression, or miR-873 knockdown plus PD-L1 knockdown. (c, d) Expression of several pluripotent transcription factors (OCT4, SOX2, Nanog, ALDH1) was examined in MDA-MB-231 cells with miR-873 overexpression or PD-L1 knockdown, or miR-873 overexpression plus PD-L1 overexpression. (e–h) Spheroid formation or CD44+/CD24- population was measured in cells depicted in (a and c). (Data were presented as the mean ± SD, n = 3. *p < 0.05, **p < 0.01, ***p < 0.001 vs Control group).

Contributor Information

Tao Xi, Email: xitao18@hotmail.com.

Lufeng Zheng, Email: zhlf@cpu.edu.cn.

Reference

  • 1.Gao L., Guo Q., Li X., Yang X., Ni H., Wang T., Zhao Q., Liu H., Xing Y., Xi T. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells. EBioMedicine. 2019;41:395–407. doi: 10.1016/j.ebiom.2019.02.034. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from EBioMedicine are provided here courtesy of Elsevier

RESOURCES